Table of Contents
Secrecy: sludge in the scientific pipeline?
Health research policy concerns
The Pipeline Is Dead
Pipeline model of innovation: strong v. weak
PPT Slide
Kernels of truth
Growth of health research
The Lasker Legacy: NIH’s Postwar Growth
PPT Slide
Health R&D as %GDP
Private R&D Exceeds Public
An analogy: integrated circuits and genomics
DARPA’s Approach to VLSI
Features of universities
Changing academic norms
Saxenian: regional advantage
Distinctive Features of Patents in Pharmaceuticals and Biotech
Drug/Medical Patents
Sequence-based firms: Competing models
Sequence-first biology
Damming information flow
Continuum of openness
Policy options: influencing academic information flow
Licensing practices
Sources of ideas and histories
Old IOM study
|